'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility.

Source:http://linkedlifedata.com/resource/pubmed/id/15808403

Cancer Lett. 2005 Apr 28 221 2 177-83

Download in:

View as

General Info

PMID
15808403